Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1992-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.75.4.1400866PMID 1400866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A cluster of male pseudohermaphrodites with 5α‐reductase deficiency in Papua New Guinea

  1991cited by this paper
• A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea.

  1991cited by this paper
• Decreased urinary C19 and C21 steroid 5 alpha-metabolites in parents of male pseudohermaphrodites with 5 alpha-reductase deficiency: detection of carriers.

  1985cited by this paper
• High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.

  1984cited by this paper
• Steroid 5 alpha-reductase deficiency in a 65-year-old male pseudohermaphrodite: the natural history, ultrastructure of the testes, and evidence for inherited enzyme heterogeneity.

  1980cited by this paper
• Post-pubertal female psychosexual orientation in incomplete male pseudohermaphroditism type 2 (5 alpha-reductase deficiency).

  1980cited by this paper
• Male pseudohermaphroditism: a comparative study of one patient with 5 alpha-reductase deficiency and three patients with the complete form of testicular feminization.

  1979cited by this paper
• Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency--a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity.

  1979cited by this paper
• Prepubertal Diagnosis of Steroid 5α-Reductase Deficiency

  1978cited by this paper
• Hereditary male pseudohermaphroditism associated with an unstable form of 5 alpha-reductase.

  1978cited by this paper
• Prepubertal diagnosis of steroid 5 alpha-reductase deficiency.

  1978cited by this paper
• Hereditary Male Pseudohermaphroditism Associated with an Unstable Form of 5α-Reductase

  1978cited by this paper
• Male pseudohermaphroditism: the complexities of male phenotypic development.

  1976cited by this paper
• Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism.

  1975cited by this paper
• Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism

  1974cited by this paper
• Developmental pattern of testosterone synthesis in the fetal gonad of the rabbit.

  1973cited by this paper
• Dihydrotestosterone formation in fetal tissues of the rabbit and rat.

  1971cited by this paper

• Testicular cytology and semen analysis in 46, XY differences/disorders of sex development (DSD): implications for fertility

  2025cites this paper
• Prostatakrebs – Prävalenz, Bedeutung und Implikationen für die Prävention und Gesundheitsförderung

  2021cites this paper
• Testosterone and Prostate Effects

  2021cites this paper
• Jean Wilson and his legacy, 50 years and counting.

  2020cites this paper
• Benign prostatic hyperplasia – what do we know?

  2020cites this paper
• Male hypogonadism: a review

  2020cites this paper
• The role of androgen signaling in male sexual development at puberty.

  2020cites this paper
• Disorders of Sex Development

  2019cites this paper
• Distinct Transcriptional Profiles of the Female, Male, and Finasteride-Induced Feminized Male Anogenital Region in Rat Fetuses.

  2019cites this paper
• The effects of Pueraria mirifica extract, diadzein and genistein in testosterone-induced prostate hyperplasia in male Sprague Dawley rats

  2019cites this paper
• Association between 5α-reductase inhibitors therapy and incidence, cancer-specific mortality, and progression of prostate cancer: evidence from a meta-analysis

  2019cites this paper
• Circular RNA of the androgen receptor gene in prostate cancer

  2018cites this paper
• Risk of Prostate Cancer in Men Treated With 5&agr;-Reductase Inhibitors—A Large Population-Based Prospective Study

  2018cites this paper
• Androgen Receptor in Health and Disease

  2017cites this paper
• The impact of genetic steroid disorders on human fertility.

  2017cites this paper
• 4.02 – Disorders of Sex Development in Males: Molecular Genetics, Epigenetics, Gender Identity, and Cognition

  2017cites this paper
• Links between lower urinary tract symptoms, intermittent hypoxia and diabetes: Causes or cures?

  2017cites this paper
• MALE CONTRACEPTION

  2017cites this paper
• Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia

  2016cites this paper
• The Role of Nuclear Factor Kappa B in Benign Prostatic Hyperplasia

  2016cites this paper
• Phenotype, genotype and gender identity in a large cohort of patients from India with 5α‐reductase 2 deficiency

  2015cites this paper
• Chapter 13B – The Impact of Genetic Steroid Disorders on Human Fertility

  2014cites this paper
• 5 α -reductase-2 Deficiency’s Effect on Human Fertility

  2014cites this paper
• The effect of 5α-reductase-2 deficiency on human fertility.

  2014cites this paper
• NEW ADVANCES IN CONTRACEPTIVE METHODS

  2013cites this paper
• Medical treatment of benign prostatic hyperplasia

  2013cites this paper
• Middlesex: A Pastoral Theological Reading

  2013cites this paper
• Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation

  2013cites this paper
• Androgen Physiology, Pharmacology and Abuse

  2013cites this paper
• Prostate cancer prevention

  2013cites this paper
• Dutasteride for the treatment of benign prostatic hyperplasia

  2013cites this paper
• Testosterone and prolactin increase carboxypeptidase‐D and nitric oxide levels to promote survival of prostate cancer cells

  2012cites this paper
• Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40–79 years

  2012cites this paper
• Estrogen and androgen signaling in the pathogenesis of BPH

  2011cites this paper
• Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

  2011cites this paper
• 17α-Estradiol and genistein inhibit high fat diet induced prostate gene expression and prostate growth in the rat.

  2011cites this paper
• The first successful paternity through in vitro fertilization-intracytoplasmic sperm injection with a man homozygous for the 5α-reductase-2 gene mutation.

  2011cites this paper
• Dutasteride: A Review of its Use in the Management of Prostate Disorders

  2011cites this paper
• Chemoprevention of prostate cancer

  2011cites this paper
• Integrated testing strategy for the study of the effects of the human pharmaceutical dutasteride on fish

  2011cites this paper
• Why Is Androgen Replacement in Males Controversial

  2011cites this paper
• Semen analysis and successful paternity by intracytoplasmic sperm injection in a man with steroid 5α-reductase-2 deficiency.

  2010cites this paper
• Pathogenesis of Prostate Cancer

  2010cites this paper
• Influence of Epilobium angustifolium and Serenoa repens extracts on cytochrome 2D2 and 3A1 expression level in rats.

  2010cites this paper
• Disorders of Sex Development

  2010cites this paper
• 5α‐Reductase Isozymes and Androgen Actions in the Prostate

  2009cites this paper
• The Prostate 69 : 595 ^ 602 ( 2009 ) Overexpressionof 5 a-ReductaseType 1 Increases Sensitivityof ProstateCancerCells to Low Concentrations of Testosterone

  2009cites this paper
• Effect of Steroid 5α-Reductase Inhibitors on Markers of Tumor Regression and Proliferation in Prostate Cancer

  2009cites this paper
• Prostate Carcinoma: Introduction

  2009cites this paper
• INTERLEUKIN-1A (IL-1A), IL-1B, IL-1RN, IL-6 AND IL-6R AND PROSTATE CANCER RISK IN AFRICAN AMERICAN AND CAUCASIAN MEN

  2009cites this paper
• Androgen receptor action in the central nervous system

  2009cites this paper
• 88 – Disorders in Male Sexual Differentiation: Molecular Genetics, Gender Identity, and Cognition

  2009cites this paper
• Immunolocalization of Steroid 5a-Reductase Type 2 in Human Prostate, Seminal Vesicle and Vas Deferens -Light and Electron Microscopic Immunohistochemistry-

  2009cites this paper
• Pre-receptor regulation of the androgen receptor.

  2008cites this paper
• Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancer.

  2008cites this paper
• Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.

  2008cites this paper
• Dihydrotestosterone levels and survival in screening-detected prostate cancer: a 15-yr follow-up study.

  2008cites this paper
• Steroid 5-alpha reductase type 2 activity in biopsies from malignant and normal prostatic tissues.

  2008cites this paper
• Levels of 5α-Reductase Type 1 and Type 2 are Increased in Localized High Grade Compared to Low Grade Prostate Cancer

  2008cites this paper
• The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database

  2008cites this paper
• Type 1 and Type 2 5α-Reductase Expression in the Development and Progression of Prostate Cancer

  2008cites this paper
• Medical Treatment of Benign Prostate Hyperplasia

  2008cites this paper
• Antiandrogenic and apoptotic effects of RU-486 on animal prostate.

  2007cites this paper
• Neoplasms and pathology of sexual developmental disorders (intersex).

  2007cites this paper
• Intraprostatic Injection of Absolute Ethanol or Botulinum Toxin as a Treatment for Benign Prostatic Hyperplasia: A Systematic Review of the Literature

  2007cites this paper
• Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function.

  2007cites this paper
• Regulation of prostate 5α‐reductase‐2 gene expression and prostate weight by dietary fat and caloric intake in the rat

  2006cites this paper
• Role of 5 alpha-reductase inhibitors in the management of prostate cancer

  2006cites this paper
• Discovery and clinical development of dutasteride, a potent dual 5alpha-reductase inhibitor.

  2006cites this paper
• The MTOPS Study: New Findings, New Insights, and Clinical Implications for the Management of BPH

  2006cites this paper
• The PCPT: New Findings, New Insights, and Clinical Implications for the Prevention of Prostate Cancer

  2006cites this paper
• Chemoprevention of prostate cancer with finasteride

  2006cites this paper
• The role of dutasteride in the treatment of benign prostatic obstruction and related conditions

  2006cites this paper
• Chemoprevention of prostate cancer.

  2006cites this paper
• Effects of male sex hormones on gender identity, sexual behavior, and cognitive function.

  2006cites this paper
• Differential alterations in 5α‐reductase type 1 and type 2 levels during development and progression of prostate cancer

  2005cites this paper
• Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.

  2005cites this paper
• 5α-Reductase Isozymes in the Prostate.

  2005cites this paper
• Mechanisms of Disease: prostate cancer—a model for cancer chemoprevention in clinical practice

  2005cites this paper
• DifferentialAlterations in 5a -ReductaseType1 andType 2 LevelsDuringDevelopment

  2005cites this paper
• In situ androgen producing enzymes in human prostate cancer.

  2005cites this paper
• What’s new in the field of prostate cancer chemoprevention?

  2005cites this paper
• Molecular Basis of Steroid Action in the Prostate.

  2005influential citation
• Messenger RNA levels and enzyme activities of 5 alpha‐reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue

  2004cites this paper
• Molekulare Mechanismen von Veränderungen und Erkrankungen der Prostata

  2004cites this paper
• The Prostate Cancer Prevention Trial: current status.

  2004cites this paper
• 5alpha-reductase: history and clinical importance.

  2004cites this paper
• Pseudohermaphroditism, Male, Due to 5α-Reductase-2 Deficiency

  2004cites this paper
• Effect of the dual 5α-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer

  2004cites this paper
• Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.

  2004cites this paper
• [Testosterone and the prostate].

  2004cites this paper
• Testosteron und Prostata

  2004cites this paper
• What’s new in the field of prostate cancer chemoprevention?

  2004cites this paper
• The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions.

  2004cites this paper
• Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.

  2004cites this paper
• Androgens in Health and Disease

  2003cites this paper
• Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.

  2003cites this paper
• Chemoprevention for prostate cancer – the way forward?

  2003cites this paper
• Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials.

  2003cites this paper
• The Prostate Cancer Prevention Trial: design, status, and promise

  2003cites this paper